Luther King Capital Management (LKCM)’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-110,491
| Closed | -$10.3M | – | 612 |
|
|
2021
Q1 | $10.3M | Sell |
110,491
-11,796
| -10% | -$1.1M | 0.06% | 145 |
|
|
2020
Q4 | $11M | Buy |
122,287
+31,885
| +35% | +$2.86M | 0.06% | 139 |
|
|
2020
Q3 | $9.34M | Sell |
90,402
-16,177
| -15% | -$1.67M | 0.06% | 136 |
|
|
2020
Q2 | $8.43M | Buy |
106,579
+48,604
| +84% | +$3.84M | 0.06% | 144 |
|
|
2020
Q1 | $3.35M | Buy |
57,975
+10,520
| +22% | +$609K | 0.03% | 181 |
|
|
2019
Q4 | $2.56M | Buy |
47,455
+7,700
| +19% | +$415K | 0.02% | 259 |
|
|
2019
Q3 | $2.08M | Buy |
39,755
+32,460
| +445% | +$1.7M | 0.02% | 269 |
|
|
2019
Q2 | $352K | Buy |
+7,295
| New | +$352K | ﹤0.01% | 443 |
|